Administration of bronchodilators further increased FEV1% to 49.00 ± 3.22% (post-FEV1%), but this change did not reach statistical significance (p = 0.100) relative to the values before treatment (45.62 ± 2.63%).
← all excerpts
Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4⁺CD25⁺Foxp3⁺ regulatory T cells in COPD.
1
0.1000
0.1000